#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Postprandial hypoglycaemia Epileptic encephalopathy Retinitis pigmentosa Dermatitis Cold type haemolytic anaemia T-cell lymphoma CDKL5 deficiency disorder Von Hippel-Lindau disease B-cell type acute leukaemia Colitis ulcerative Phenylketonuria Parkinson's disease Prostate cancer Hodgkin's disease recurrent Ureteric cancer More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung – Diagnostics Lysosomal storage disorder – Trials in Disease Acute respiratory distress syndrome – Basic Information Primary biliary cholangitis – Basic Information Noonan syndrome – Treatment Splenic marginal zone lymphoma – Diagnostics Testicular leiomyosarcoma – Diagnostics Breast angiosarcoma – Basic Information Myelodysplastic syndrome – Basic Information Alternating hemiplegia of childhood – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ro7790121 Varenicline Clofutriben Insulin Human (Rdna) Olive Oil, Refined Selexipag Kbp-336 Human Coagulation Factor X Dextromethorphan Hydrobromide DISODIUM PHOSPHATE Levothyroxine Sodium Treprostinil Palmitil Dazukibart Milnacipran Hydrochloride Benzathine Benzylpenicillin Ethinylestradiol Ciclosporin Sertindole 2,4 DICHLOROBENZYL ALCOHOL Levofloxacin Hemihydrate More therapies…

    Learn about Your Condition

    Sexual dysfunction Actinic keratosis Obliterative bronchiolitis Pseudomyxoma peritonei Otitis media Gallbladder cancer Polycystic ovarian syndrome Ear discomfort Infection Herpes virus infection Systemic mastocytosis Microvillous inclusion disease Sepsis Autism spectrum disorder Vulvovaginal pruritus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiogenic shock

  • Study on Isoflurane, Propofol, and Dobutamine Hydrochloride for Sedation in Adults with Severe Cardiogenic Shock on ECMO

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Isoflurane
    • Propofol
    France

  • Study on the Early Use of Levosimendan Compared to Placebo for Patients with Cardiogenic Shock

    Recruiting

    3 1 1
    Investigated Drugs:
    • Biotin
    • Cocarboxylase Tetrahydrate
    • Dexpanthenol
    France

  • Study of Lower Blood Pressure Targets Using Noradrenaline in Patients with Heart Attack-Related Cardiogenic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    • Acute myocardial infarction
    Investigated Drugs:
    • Noradrenaline Tartrate
    Belgium Czechia Denmark Germany Greece The Netherlands +3

  • Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Cocarboxylase Tetrahydrate
    • D-Biotin
    • Dexpanthenol
    Austria

  • Study on the Effects of Empagliflozin for Patients with Cardiogenic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Empagliflozin
    France

  • Study on Cangrelor and Bivalirudin for Patients with Heart Attack-Related Cardiogenic Shock or Cardiac Arrest on VA-ECMO Support

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Cangrelor Tetrasodium
    Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!